healthdatainsight.org.uk
  • About
    • About
    • Partnerships
    • Contact
  • People
    • The Team
    • Directors
  • Services
    • Data Services
    • Project Management
    • Technology Solutions
    • Consultancy
  • Outputs
    • All projects
    • Publications
  • Work with us
    • Vacancies
    • HDI Internships
  • News
Select Page

Amivantimab versus real-world clinical practice in Europe and the US for patients with advanced non-small cell lung cancer with activating epidermal growth factor receptor exon 20 insertion mutations

Nov 6, 2022

Home » Archives for Rosemarie Gant » Page 11 Girard N, Wolf J, Kron A, Scheffler M, Knott CS Bosquet L et al. Amivantimab versus real-world clinical practice in Europe and the US for patients with advanced non-small cell lung cancer with activating epidermal growth...

Factors associated with the receipt of systemic treatment (tx) for metastatic urothelial carcinoma (mUC) in England

Sep 9, 2022

Home » Archives for Rosemarie Gant » Page 11 Kearney M, Knott CS, Mahmoudpour H, Verpillat P. Factors associated with the receipt of systemic treatment (tx) for metastatic urothelial carcinoma (mUC) in England. ESMO 2022; 2022 Sept...

Evolution of the treatment landscape in patients with advanced or metastatic cancers following the approval of immuno-oncology treatments

Aug 24, 2022

Home » Archives for Rosemarie Gant » Page 11 Mahmoudpour H, Knott CS, Amin A, Boutmy E, Verpillat P. Evolution of the treatment landscape in patients with advanced or metastatic cancers following the approval of immuno-oncology treatments: analysis of the England...

Comparison of survival outcomes between dostarlimab and comparator treatments (tx) in patients (pts) with advanced/recurrent (A/R) endometrial cancer (EC) in England

Jun 3, 2022

Home » Archives for Rosemarie Gant » Page 11 Goulden S, Heffernan K, Nikitas FS, Shukla U, Knott CS, Hunger M, Pahwa A, Schade R. Comparison of survival outcomes between dostarlimab and comparator treatments (tx) in patients (pts) with advanced/recurrent (A/R)...

Cohort profile of the Sloane Project: methodology for a prospective UK cohort study of >15 000 women with screen-detected non-invasive breast neoplasia.

Dec 19, 2022

Home » Archives for Rosemarie Gant » Page 16 Clements K, Dodwell D, Hilton B, Stevens-Harris I, Pinder S, Wallis MG, et al.BMJ Open 2022;12: e061585. http://dx.doi.org/10.1136/bmjopen-2022-061585corr1 Abstract: ​Purpose The introduction of breast screening in the UK...

Characteristics, treatment patterns and outcomes of patients with newly diagnosed advanced ovarian cancer (aOC) in England

Oct 20, 2022

Home » Archives for Rosemarie Gant » Page 16 Angela Whittle, Betina Blak, Amy Zalin-Miller, Orlaith Condon (2022) ‘Characteristics, treatment patterns and outcomes of patients with newly diagnosed advanced ovarian cancer (aOC) in England’; abstract accepted at...
« Older Entries

Quick Links

About
The Team
Directors
Projects
HDI Internships
News
Contact

Featured Projects

Simulacrum v2
Kidney Cancer UK
PEUGIC
CanGene CanVar
Cholangiocarcinoma

All projects

Contact us |Privacy Policy

Follow Us

Health Data Insight CIC is a Community Interest Company. Registration number 7700799. Registered address: CPC4, Capital Park, Fulbourn, Cambridge CB21 5XE. Copyright © 2025 Health Data Insight CIC

We use cookies as part of our site security. If you continue to use this site we will assume that you are happy with this.OKPrivacy policy